BioSpace News Archive

Medications for lupus — a long-term autoimmune disease that occurs when a person’s immune system attacks different parts of their body, including their skin — are currently being explored as a treatment for COVID-19 patients.

BioSig Technologies, Inc. appointed Mr. Anthony Zook to the Board of Directors of its majority-owned subsidiary ViralClear Pharmaceuticals, Inc.

This milestone marks the fifth study for IMBRUVICA to bring a chemo-free treatment option to patients with CLL and the sixth approval for IMBRUVICA in CLL

Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company

The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.

Surmodics, Inc. today announced that it will host a live webcast of its second quarter fiscal 2020 conference call on Wednesday, April 29, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon. Gar

Lenco Diagnostic Laboratories, one of NYC’s largest privately-owned full service reference laboratories, provides an update on COVID-19 testing and recently launched IgG and IgM serology testing to detect antibodies against COVID-19.

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.

Investigator initiated study at Sweden’s Karolinska Institutet to test COVID-19 pneumonia patients with Unyvero HPN panel for bacterial co-infections

OrthoPediatrics Corp. announced that the Company is scheduled to release its first quarter 2020 financial results on Tuesday, May 5, 2020, after the market closes.